Julie E. Penzotti

Predicting ADME properties and side effects: the BioPrint approach.

Cecile M. Krejsa, Dragos Horvath, Sherri L Rogalski et al. · PubMed · 2003 · 179 citations

Drug Target, Hit Identification, Biomedical Engineering +16

Structural Basis of Specificity and Degeneracy of T Cell Recognition: Pluriallelic Restriction of T Cell Responses to a Peptide Antigen Involves Both Specific and Promiscuous Interactions Between the T Cell Receptor, Peptide, and HLA-DR

Derek G. Doherty, Julie E. Penzotti, David M. Koelle et al. · The Journal of Immunology · 1998 · 85 citations

Histocompatibility, T Cell Responses, Other Dr4 +22

A Rapid Computational Method for Lead Evolution:  Description and Application to α₁-Adrenergic Antagonists

Erin K. Bradley, Paul Beroza, Julie E. Penzotti et al. · Journal of Medicinal Chemistry · 2000 · 66 citations · Full text

Drug Target, Hit Identification, Lead Identification +19

A structural snapshot of an intermediate on the streptavidin–biotin dissociation pathway

Stefanie Freitag, Vano Chu, Julie E. Penzotti et al. · Proceedings of the National Academy of Sciences · 1999 · 66 citations · Full text

Machine-learning models for combinatorial catalyst discovery

Gregory A. Landrum, Julie E. Penzotti, Santosh Putta · Measurement Science and Technology · 2004 · 51 citations

Engineering, Machine Learning, Bag Classifiers +22